Confidence Intervals Favored Over P-Values In FDA Clinical Studies Guidance

P-values are not an adequate measure of uncertainty in describing the clinical outcome of a treatment relative to a comparator, FDA maintains in a draft guidance on the Clinical Studies section of labeling.